➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Medtronic
AstraZeneca
McKinsey

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Telotristat ethyl

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Telotristat ethyl?

Telotristat ethyl is an investigational drug.

There have been 12 clinical trials for Telotristat ethyl. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2020.

The most common disease conditions in clinical trials are Neuroendocrine Tumors, Carcinoid Tumor, and Malignant Carcinoid Syndrome. The leading clinical trial sponsors are Lexicon Pharmaceuticals, Ipsen, and Emory University.

There are twelve US patents protecting this investigational drug and one hundred and eleven international patents.

Recent Clinical Trials for Telotristat ethyl
TitleSponsorPhase
Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine TumorsUniversity of ChicagoPhase 2
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic CancerLexicon PharmaceuticalsPhase 2
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic CancerEmory UniversityPhase 2

See all Telotristat ethyl clinical trials

Clinical Trial Summary for Telotristat ethyl

Top disease conditions for Telotristat ethyl
Top clinical trial sponsors for Telotristat ethyl

See all Telotristat ethyl clinical trials

US Patents for Telotristat ethyl

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Telotristat ethyl   Start Trial Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase ACTELION PHARMACEUTICALS LTD (Allschwil, CH)   Start Trial
Telotristat ethyl   Start Trial 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   Start Trial
Telotristat ethyl   Start Trial 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Telotristat ethyl

Drugname Country Document Number Estimated Expiration Related US Patent
Telotristat ethyl Canada CA2927121 2033-11-19   Start Trial
Telotristat ethyl China CN105745211 2033-11-19   Start Trial
Telotristat ethyl European Patent Office EP3071567 2033-11-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Medtronic
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.